跳至主要内容
临床试验/NL-OMON56420
NL-OMON56420招募中不适用

ong-term effects of a potato-based food pattern vs a rice / pasta-based food pattern on fasting & postprandial cardiometabolic health; The LoPoCardio - trial - Potatoes and cardiometabolic health

niversiteit Maastricht0 个研究点目标入组 56 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Men and women
  • - Aged between 40-70 years
  • - BMI between 25-35 kg/m2 (overweight and obese)
  • - Serum total cholesterol < 8.0 mmol/L (further testing is recommended for
  • excessive hyperlipidemia [serum total cholesterol >= 8.0 mmol/L] according to
  • the Standard for cardiovascular risk management of the Dutch general
  • practitioners community [NHG])
  • - Serum triacylglycerol < 4.52 mmol/L
  • - No current smoker
  • - No diabetic patients
  • - No familial hypercholesterolemia
  • - No abuse of drugs
  • - Not more than 4 alcoholic consumption per day with a maximum of 21 per week
  • - Stable body weight (weight gain or loss < 3 kg in the past three months)
  • - No use of medication known to treat blood pressure, lipid or glucose
  • - No use of an investigational product within another biomedical intervention
  • trial within the previous 1-month
  • - No severe medical conditions that might interfere with the study, such as
  • epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive
  • pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and
  • rheumatoid arthritis
  • - No active cardiovascular disease like congestive heart failure or
  • cardiovascular event, such as an acute myocardial infarction or cerebrovascular
  • - Willingness to give up being a blood donor from 8 weeks before the start of
  • the study, during the study and for 4 weeks after completion of the study
  • - No difficult venipuncture as evidenced during the screening visit
  • - Willing to comply to study protocol during study
  • - Informed consent signed

排除标准

  • - Allergy or intolerance to potatoes, pasta or rice
  • - Serum total cholesterol >= 8.0 mmol/L
  • - Serum triacylglycerol >= 4.52 mmol/L
  • - Current smoker, or smoking cessation <12 months
  • - Diabetic patients
  • - Familial hypercholesterolemia
  • - Abuse of drugs
  • - More than 4 alcoholic consumptions per day or 21 per week
  • - Unstable body weight (weight gain or loss > 3 kg in the past three months)
  • - Use medication known to treat blood pressure, lipid or glucose metabolism
  • - Use of an investigational product within another biomedical intervention
  • trial within the previous 1-month
  • - Severe medical conditions that might interfere with the study, such as
  • epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive
  • pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and
  • rheumatoid arthritis
  • - Active cardiovascular disease like congestive heart failure or
  • cardiovascular event, such as an acute myocardial infarction or cerebrovascular
  • - Not willing to give up being a blood donor from 8 weeks before the start of
  • the study, during the study or for 4 weeks after completion of the study
  • - Not or difficult to venipuncture as evidenced during the screening visit
  • - Use of over-the-counter and prescribed medication or supplements, which may
  • interfere with study measurements to be judged by the principal investigator;
  • - Use of oral antibiotics in 40 days or less prior to the start of the study;
  • - Blood donation in the past 3 months before the start of the study
  • - Not willing to comply to study protocol during study or sign informed consent

研究者

相似试验